3B Blackbio Dx Limited (NSE:3BBLACKBIO)

3B Blackbio Dx Revenue

3B Blackbio Dx had revenue of 334.91M INR in the quarter ending June 30, 2026, with 50.62% growth. This brings the company's total for the last twelve months to 1.53B, up 54.30% year-over-year. In the fiscal year ending March 31, 2026, 3B Blackbio Dx had annual revenue of 1.42B with 47.11% growth.

• Revenue (ttm): 1.53B
• Revenue Growth: +54.30%
• P/S Ratio: 7.22
• Revenue / Employee: 17.81M
• Employees: 86
• Market Cap: 11.06B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Diagnostic Kits 1.31B 92.4%
• Agrochemicals 108.00M 7.6%

Fiscal year ended Mar 31, 2026 See the full 3B Blackbio Dx breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.42B	454.50M	47.11%
Mar 31, 2025	964.69M	220.55M	29.64%
Mar 31, 2024	744.13M	123.45M	19.89%
Mar 31, 2023	620.68M	-254.81M	-29.11%
Mar 31, 2022	875.50M	-1.42B	-61.87%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error